Eli Lilly and Company (LLY) Foundayo™ (orforglipron), Lilly’s new oral GLP-1 pill for weight loss, now available in the U.S.

Eli Lilly and Company (NYSE: LLY) FY 2026 Product Release

Newsdesk: